4-Methoxy-N,N'-bis(3-pyridinylmethyl)-1,3-benzenedicarboxamide; UNII-654G2VCI4Q; 654G2VCI4Q; Plactidil; 4-methoxy-1-N,3-N-bis(pyridin-3-ylmethyl)benzene-1,3-dicarboxamide; Picotamide [INN:BAN]; EINECS 251-245-7; BRN 0499268; 4-Methoxy-N,N'-bis(3-pyridylmethyl)isophthaldiamide; SR-01000076086; G 137; N,N'-Bis(3-picolyl)-4-methoxyisophthalamide; Plactidil (TN); 4-Methoxy-N,N'-bis(3-pyridylmethyl)isophthalamide; Picotamide (BAN); N,N'-Bis(3-pyridinylmethyl)-4-methoxy-1,3-benzenedicarboxamide; Prestwick0_000119; Prestwick1_000119; Prestwick2_000119; Prestwick3_000119; Lopac-P-8477; G-137; Lopac0_001003; BSPBio_000138; N,N'-Bis(3-pyridylmethyl)-4-methoxyisophthalamide; SCHEMBL137025; SPBio_002077; BPBio1_000152; CHEMBL1257015; CTK8G2414; DTXSID40186498; HMS2090L18; HMS3263I07; ZINC538174; Tox21_501003; 1,3-Benzenedicarboxamide, N,N'-bis(3-pyridinylmethyl)-4-methoxy-; BDBM50103507; MFCD00866792; NSC304384; CCG-205083; DB13327; LP01003; NSC-304384; SDCCGSBI-0050976.P003; (S)-(-)-2-METHOXYPROPIONICACID; NCGC00015847-01; NCGC00015847-02; NCGC00015847-03; NCGC00015847-04; NCGC00015847-05; NCGC00094297-01; NCGC00094297-02; NCGC00261688-01; SBI-0050976.P002; DB-048275; EU-0101003; FT-0630565; D07140; P 8477; 199353-EP2277879A1; 828P812; L013375; J-018896; Q1235921; SR-01000076086-1; 4-methoxy-N1,N3-bis(pyridin-3-ylmethyl)isophthalamide; BRD-K67277431-002-03-0; Isophthalamide, 4-methoxy-N,N'-bis(3-pyridylmethyl)- (8CI); 4-methoxy-N1,N3-bis(3-pyridinylmethyl)benzene-1,3-dicarboxamide